ACCENTIS NV (ACCB.BR)       0.0328  +0 (+2.5%)

0.0328  +0 (+2.5%)

BE0003696102 - Common Stock


Fundamental Rating

6

Taking everything into account, ACCB scores 6 out of 10 in our fundamental rating. ACCB was compared to 23 industry peers in the Real Estate Management & Development industry. ACCB gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on ACCB. This makes ACCB very considerable for value investing!.

Note: ACCB has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

7

ACCB's Return On Assets of 24.17% is amongst the best returns of the industry. ACCB outperforms 100% of its industry peers. The industry average Return On Assets is 3.17%.
ACCB's Return On Equity of 40.23% is amongst the best returns of the industry. ACCB outperforms 100% of its industry peers. The industry average return on equity is 11.79%.

ACCB has a Profit Margin of 103.41%. This is better than the industry average of 38.16%.
ACCB has a Piotroski-F score of 6.00. This indicates an average health and profitability for ACCB.
VS Industry

ROA (24.17%) VS Industry: 100% outperformed.

-82.80
24.17

ROE (40.23%) VS Industry: 100% outperformed.

2.82
40.23

Profit Margin (103.41%) VS Industry: 61% outperformed.

-239.44
978.77

Valuation

Valuation Rating

7

With a Price/Earnings Ratio of 3.28, the valuation of ACCB can be described as very cheap.
ACCB's Price/Earning Ratio is rather cheap when compared to the industry average which is at 8.10. ACCB is also cheaper than 83% of the companies in the same industry.
ACCB's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the Enterprise Value to EBITDA ratio of ACCB to the average industry ratio of 15.16, ACCB is valued rather cheaply.
With a price book ratio of 1.15, ACCB is valued correctly.
When comparing the price book ratio of ACCB to the average industry price book ratio of 0.56, ACCB is valued more expensive than its industry peers. 91% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (3.28) VS Industry: 83% outperformed.

670.00
2.49

Price/Book (1.15) VS Industry: 9% outperformed.

1.38
0.08

Enterprise Value/ EBITDA (6.83) VS Industry: 76% outperformed.

27.00
2.40

Growth

Growth Rating

5

The Earnings Per Share has grown by an impressive 148.64% over the past year.
ACCB shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 35.88% yearly.

The Revenue has been growing slightly by 0.70% on average over the past 5 years.
Looking at the last year, ACCB shows a very negative growth in Revenue. The Revenue has decreased by -33.67% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS35.88% 32.93% 148.64% N/A N/A N/A N/A
Revenue0.7% 1.57% -33.67% N/A N/A N/A N/A

Health

Health Rating

8

A Current Ratio of 2.37 indicates that ACCB has no problem at all paying its short term obligations.
ACCB is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.95.
ACCB has a Quick Ratio of 2.37. This indicates that ACCB is financially healthy and has no problem in meeting its short term obligations.
ACCB is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.73.

With a Debt to Equity ratio of 0.41, ACCB is doing better than the averages in the industry. The industry average is at 0.73.
The Altman-Z score of ACCB is much better than the industry average of 1.06. ACCB has a better rating than 95% of its industry peers.
An Altman-Z score of 2.55 indicates that ACCB is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACCB has a Piotroski-F score of 6.00. This indicates an average health and profitability for ACCB.
VS Industry

Debt/Equity (0.41) VS Industry: 72% outperformed.

2.78
0.00

Quick Ratio (2.37) VS Industry: 71% outperformed.

0.13
5.78

Current Ratio (2.37) VS Industry: 66% outperformed.

0.13
5.78

Altman-Z (2.55) VS Industry: 95% outperformed.

-3.63
10.78

Dividend

Dividend Rating

0

ACCB does not give a dividend.

ACCB Daily chart

ACCENTIS NV0.0328

EBR:ACCB (9/23/2022, 7:00:00 PM)+0 (+2.5%)

Chartmill FA Rating
GICS Sector Real Estate
GICS IndustryGroup Real Estate
GICS Industry Real Estate Management & Development
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners N/A
Market Cap 41.42M Analysts N/A
Valuation
PE 3.28 Fwd PE N/A
PEG (NY) N/A PEG (5Y) 0.09
P/S 2.96 P/B 1.15
EV/EBITDA 6.83
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y 148.64% EPS 3Y 32.93%
EPS 5Y 35.88% EPS growth Q2Q -80.63%
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y -33.67% Revenue growth 3Y 1.57%
Revenue growth 5Y 0.7% Revenue growth Q2Q -64.62%
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
Health
Current Ratio 2.37 Quick Ratio 2.37
Altman-Z 2.55 F-Score 6
Debt/Equity 0.41
Profitability
ROA 24.17% ROE 40.23%
ROIC 7.76% ROICg 7.76%
PM 103.41 OM 35.45
Asset Turnover 0.23

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext